“…Unilateral transplantation of fetal tissue was used in the first human clinical Parkinson's disease transplant trials [3,4,38]. Typically implants were made into the side of brain contralateral to the side of the body with the worse Parkinson's symptoms.…”
Section: Unilateral Versus Bilateral Transplantationmentioning
confidence: 99%
“…Within 5 months, it was obvious that the unilateral transplant had improved motor performance only contralateral to the side of transplant [3]. Therefore, beginning with our third subject, we have performed bilateral, simultaneous implantation of fetal dopamine neurons into the putamen.…”
Section: Unilateral Versus Bilateral Transplantationmentioning
confidence: 99%
“…Beginning with our first human transplant in 1988, we took the position that immunosuppression may not be necessary [3]. Because transplants of fetal dopamine neurons offer the potential for only symptomatic relief of the of Parkinson's disease symptoms, and because immunosuppression is expensive and carries substantial long-term medical risks, we decided not to immunosuppress our first subject [3]. After that we used immunosuppression in 6 of our first 12 transplant patients and found that immunosuppression did not improve transplant outcome [5].…”
Section: Immunology Of Transplantsmentioning
confidence: 99%
“…Dyskinesias have appeared in transplant recipients who had L-DOPA-induced dyskinesias prior to transplant [3,5,7,9,[48][49][50][51][52]. In nearly all patients who have responded to transplants, there is an initial period of increased dyskinesias, which resolves as drug doses are reduced.…”
Section: Transplants That Replace the Need For L-dopa Can Replicate Dmentioning
confidence: 99%
“…For human transplantation, the equivalent stage of embryonic development is 6 to 8 weeks after conception [3][4][5]. All successful allografts of human embryonic tissue into patients with Parkinson's disease have come from tissue in this developmental window.…”
“…Unilateral transplantation of fetal tissue was used in the first human clinical Parkinson's disease transplant trials [3,4,38]. Typically implants were made into the side of brain contralateral to the side of the body with the worse Parkinson's symptoms.…”
Section: Unilateral Versus Bilateral Transplantationmentioning
confidence: 99%
“…Within 5 months, it was obvious that the unilateral transplant had improved motor performance only contralateral to the side of transplant [3]. Therefore, beginning with our third subject, we have performed bilateral, simultaneous implantation of fetal dopamine neurons into the putamen.…”
Section: Unilateral Versus Bilateral Transplantationmentioning
confidence: 99%
“…Beginning with our first human transplant in 1988, we took the position that immunosuppression may not be necessary [3]. Because transplants of fetal dopamine neurons offer the potential for only symptomatic relief of the of Parkinson's disease symptoms, and because immunosuppression is expensive and carries substantial long-term medical risks, we decided not to immunosuppress our first subject [3]. After that we used immunosuppression in 6 of our first 12 transplant patients and found that immunosuppression did not improve transplant outcome [5].…”
Section: Immunology Of Transplantsmentioning
confidence: 99%
“…Dyskinesias have appeared in transplant recipients who had L-DOPA-induced dyskinesias prior to transplant [3,5,7,9,[48][49][50][51][52]. In nearly all patients who have responded to transplants, there is an initial period of increased dyskinesias, which resolves as drug doses are reduced.…”
Section: Transplants That Replace the Need For L-dopa Can Replicate Dmentioning
confidence: 99%
“…For human transplantation, the equivalent stage of embryonic development is 6 to 8 weeks after conception [3][4][5]. All successful allografts of human embryonic tissue into patients with Parkinson's disease have come from tissue in this developmental window.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.